Evidence map›Paper›PMID 33551509›Full record

ArticleBulletin of the World Health Organization2021

Immunity certification for COVID-19: ethical considerations.

Teck Chuan Voo, Andreas A Reis, Beatriz Thomé, Calvin Wl Ho, Clarence C Tam, Cassandra Kelly-Cirino, Ezekiel Emanuel, Juan P Beca, Katherine Littler, Maxwell J Smith and 7 more

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. COVID-19 response and mitigation: a call for action.Bulletin of the World Health Organization · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Teck Chuan VooCentre for Biomedical Ethics, National University of Singapore, Blk MD 11, 10 Medical Drive #02-03, Singapore117597, Singapore.
Andreas A ReisHealth Ethics and Governance Unit, World Health Organization, Geneva, Switzerland.
Beatriz ThoméPreventive Medicine Department, Federal University of São Paulo, São Paulo, Brazil.
Calvin Wl HoFaculty of Law, University of Hong Kong, Hong Kong Special Administrative Region, China.
Clarence C TamSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Cassandra Kelly-CirinoFoundation for Innovative New Diagnostics, Geneva, Switzerland.
Ezekiel EmanuelDepartment of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, United States of America.
Juan P BecaCentro de Bioética, Universidad del Desarrollo, Santiago, Chile.
Katherine LittlerHealth Ethics and Governance Unit, World Health Organization, Geneva, Switzerland.
Maxwell J SmithFaculty of Health Sciences, Western University, Ontario, Canada.
Michael ParkerWellcome Centre of Ethics and Humanities, University of Oxford, Oxford, England.
Nancy KassBerman Institute of Bioethics and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA.
Nina GobatNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England.
Ruipeng LeiSchool of Philosophy and Center for Bioethics, Huazhong University of Science and Technology, Wuhan, China.
Ross UpshurDalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Samia HurstInstitute for Ethics, History, and the Humanities, University of Geneva, Geneva, Switzerland.
Sody MunsakaSchool of Health Sciences, University of Zambia, Lusaka, Zambia.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Restrictive measures imposed because of the coronavirus disease 2019 (COVID-19) pandemic have resulted in severe social, economic and health effects. Some countries have considered the use of immunity certification as a strategy to relax these measures for people who have recovered from the infection by issuing these individuals a document, commonly called an immunity passport. This document certifies them as having protective immunity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19. The World Health Organization has advised against the implementation of immunity certification at present because of uncertainty about whether long-term immunity truly exists for those who have recovered from COVID-19 and concerns over the reliability of the proposed serological test method for determining immunity. Immunity certification can only be considered if scientific thresholds for assuring immunity are met, whether based on antibodies or other criteria. However, even if immunity certification became well supported by science, it has many ethical issues in terms of different restrictions on individual liberties and its implementation process. We examine the main considerations for the ethical acceptability of immunity certification to exempt individuals from restrictive measures during the COVID-19 pandemic. As well as needing to meet robust scientific criteria, the ethical acceptability of immunity certification depends on its uses and policy objectives and the measures in place to reduce potential harms, and prevent disproportionate burdens on non-certified individuals and violation of individual liberties and rights.

Indexed as

PandemicsCertificationCOVID-19COVID-19 Serological TestingHumansImmunity, HumoralPublic Health

Identifiers

PMID33551509
PMCPMC7856365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.